Exact Sciences’ stock tumbled as fears of a sales slowdown spooked investors. While the company’s outlook calls for better growth in the back half of the year, Cologuard sales will have to accelerate. (Investor’s Business Daily)
Acelyrin announced that Shao-Lee Lin is stepping down as CEO. The drug developer disclosed the leadership shuffle and scrapped its planned first-quarter earnings call. (Endpoints News)
Amid growing concern over the widespread outbreak of avian influenza among U.S. dairy cattle, the monitoring of farmworkers who have been exposed to sick cows has been severely limited. Only one U.S. dairy farmworker has tested positive for the virus, known as H5N1, though there have been anecdotal reports of ill workers on farms where cows were also sick. (Barron’s)
A 30-year study found that eating ultraprocessed foods is linked to a higher risk of early death. The results varied based on which foods people ate, but meat, poultry and seafood “ready-to-eat” products showed strong associations with mortality. (The Hill)
The United States spent more than $722 billion on prescription drugs in 2023, according to a recent report. That represents a nearly 14% increase in spending from 2022, which is expected to continue this year. (AARP)
Click here to view yesterday’s Five things for pharma marketers to know.
